InvestorsHub Logo
Followers 62
Posts 3684
Boards Moderated 0
Alias Born 11/21/2018

Re: Bill B post# 32488

Wednesday, 12/16/2020 3:27:18 PM

Wednesday, December 16, 2020 3:27:18 PM

Post# of 44690
Aviptadil shown 75% efficacy in expanded access trials treated over 200 critical covid patients in that setting and no “therapy” had shown such efficacy in expanded access. Results from randomized covid trials will be out any moment. RLFTF had Fast Track and “priority review”

amr*n never going to finish p3 trials don’t even try to compare with $RLFTF